Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
Status: Enrolling
Updated:  12/31/1969
Sheppard Pratt
mi
from
Baltimore, MD
D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
Status: Enrolling
Updated: 12/31/1969
Sheppard Pratt
mi
from
Baltimore, MD
Click here to add this to my saved trials
D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
Status: Enrolling
Updated:  12/31/1969
New York Langone Medical Center/Bellevue Hospital
mi
from
New York, NY
D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
Status: Enrolling
Updated: 12/31/1969
New York Langone Medical Center/Bellevue Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Cognitive Remediation of Schizophrenia in a Community Mental Health Setting
Cognitive Remediation of Schizophrenia in a Community Mental Health Setting
Status: Enrolling
Updated:  12/31/1969
vinogradov research lab SFVAMC
mi
from
San Francisco, CA
Cognitive Remediation of Schizophrenia in a Community Mental Health Setting
Cognitive Remediation of Schizophrenia in a Community Mental Health Setting
Status: Enrolling
Updated: 12/31/1969
vinogradov research lab SFVAMC
mi
from
San Francisco, CA
Click here to add this to my saved trials
Get Moving and Get Well - Pilot Study
Get Moving and Get Well: A Behavioral Activation Program for Veterans With SMI
Status: Enrolling
Updated:  12/31/1969
Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR
mi
from
North Little Rock, AR
Get Moving and Get Well - Pilot Study
Get Moving and Get Well: A Behavioral Activation Program for Veterans With SMI
Status: Enrolling
Updated: 12/31/1969
Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR
mi
from
North Little Rock, AR
Click here to add this to my saved trials
Building Employment Skills Through Therapy for Veterans
Integrated Cognitive Behavior Therapy to Improve Work Outcomes in Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
mi
from
Philadelphia, PA
Building Employment Skills Through Therapy for Veterans
Integrated Cognitive Behavior Therapy to Improve Work Outcomes in Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated:  12/31/1969
C.I. Trials, Inc.-Los Angeles County
mi
from
Bellflower, CA
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated: 12/31/1969
C.I. Trials, Inc.-Los Angeles County
mi
from
Bellflower, CA
Click here to add this to my saved trials
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated:  12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated: 12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated:  12/31/1969
University of California, Riverside at C.I. Trials, Inc.-Inland Empire
mi
from
Riverside, CA
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated: 12/31/1969
University of California, Riverside at C.I. Trials, Inc.-Inland Empire
mi
from
Riverside, CA
Click here to add this to my saved trials
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated:  12/31/1969
C.I. Trials, Inc.-Orange County
mi
from
Santa Ana, CA
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated: 12/31/1969
C.I. Trials, Inc.-Orange County
mi
from
Santa Ana, CA
Click here to add this to my saved trials
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Yale University
mi
from
New Haven, CT
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Innovative Clinical Research, Inc
mi
from
Lauderhill, FL
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Innovative Clinical Research, Inc
mi
from
Lauderhill, FL
Click here to add this to my saved trials
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Prevention and Recovery Center for Early Psychosis
mi
from
Indianapolis, IN
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Prevention and Recovery Center for Early Psychosis
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Indiana University Psychotic Disorders Clinic
mi
from
Indianapolis, IN
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Indiana University Psychotic Disorders Clinic
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Maryland Psychiatric Research Center
mi
from
Baltimore, MD
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Maryland Psychiatric Research Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Centers for Behavioral Health, LLC
mi
from
Rockville, MD
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Centers for Behavioral Health, LLC
mi
from
Rockville, MD
Click here to add this to my saved trials
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Sheppard Pratt Health System
mi
from
Towson, MD
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Sheppard Pratt Health System
mi
from
Towson, MD
Click here to add this to my saved trials
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Laureate Institute for Brain Research
mi
from
Tulsa, OK
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Laureate Institute for Brain Research
mi
from
Tulsa, OK
Click here to add this to my saved trials
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated:  12/31/1969
University of Kansas Medical Center-Witchita
mi
from
Wichita, KA
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Status: Enrolling
Updated: 12/31/1969
University of Kansas Medical Center-Witchita
mi
from
Wichita, KA
Click here to add this to my saved trials
Project Bridge: Peer Health Navigator Intervention
A Randomized Controlled Trial of "The Bridge", a Peer Health Navigation Intervention
Status: Enrolling
Updated:  12/31/1969
Pacific Clinics El Camino
mi
from
Santa Fe Springs, CA
Project Bridge: Peer Health Navigator Intervention
A Randomized Controlled Trial of "The Bridge", a Peer Health Navigation Intervention
Status: Enrolling
Updated: 12/31/1969
Pacific Clinics El Camino
mi
from
Santa Fe Springs, CA
Click here to add this to my saved trials
Comparison of E-health vs. In-person MFG
Comparison of E-Health vs. In-Person Delivered Family Psychoeducation Treatment
Status: Enrolling
Updated:  12/31/1969
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
mi
from
Pittsburgh, PA
Comparison of E-health vs. In-person MFG
Comparison of E-Health vs. In-Person Delivered Family Psychoeducation Treatment
Status: Enrolling
Updated: 12/31/1969
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Glutamate, Brain Connectivity and Duration of Untreated Psychosis
Glutamate, Brain Connectivity and Duration of Untreated Psychosis
Status: Enrolling
Updated:  12/31/1969
Sparks Center
mi
from
Birmingham, AL
Glutamate, Brain Connectivity and Duration of Untreated Psychosis
Glutamate, Brain Connectivity and Duration of Untreated Psychosis
Status: Enrolling
Updated: 12/31/1969
Sparks Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Tocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia
Tocilizumab, An IL-6 Receptor Antibody, As Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Status: Enrolling
Updated:  12/31/1969
New York State Psychiatric Institute
mi
from
New York, NY
Tocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia
Tocilizumab, An IL-6 Receptor Antibody, As Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Status: Enrolling
Updated: 12/31/1969
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Randomized Controlled Trial (RCT) of a Motivational Decision Support System
RCT of a Motivational Decision Support System for Smokers With Severe Mental Illnesses
Status: Enrolling
Updated:  12/31/1969
Thresholds
mi
from
Chicago, IL
Randomized Controlled Trial (RCT) of a Motivational Decision Support System
RCT of a Motivational Decision Support System for Smokers With Severe Mental Illnesses
Status: Enrolling
Updated: 12/31/1969
Thresholds
mi
from
Chicago, IL
Click here to add this to my saved trials
Randomized Controlled Trial (RCT) of a Motivational Decision Support System
RCT of a Motivational Decision Support System for Smokers With Severe Mental Illnesses
Status: Enrolling
Updated:  12/31/1969
Rutgers-UNDMJ
mi
from
New Brunswick, NJ
Randomized Controlled Trial (RCT) of a Motivational Decision Support System
RCT of a Motivational Decision Support System for Smokers With Severe Mental Illnesses
Status: Enrolling
Updated: 12/31/1969
Rutgers-UNDMJ
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Randomized Controlled Trial (RCT) of a Motivational Decision Support System
RCT of a Motivational Decision Support System for Smokers With Severe Mental Illnesses
Status: Enrolling
Updated:  12/31/1969
University of Massachusetts
mi
from
Worcester, MA
Randomized Controlled Trial (RCT) of a Motivational Decision Support System
RCT of a Motivational Decision Support System for Smokers With Severe Mental Illnesses
Status: Enrolling
Updated: 12/31/1969
University of Massachusetts
mi
from
Worcester, MA
Click here to add this to my saved trials
Optimizing Cognitive Remediation Outcomes in Schizophrenia
Optimizing Cognitive Remediation Outcomes in Schizophrenia
Status: Enrolling
Updated:  12/31/1969
San Francisco Veterans Medical Center
mi
from
San Francisco, CA
Optimizing Cognitive Remediation Outcomes in Schizophrenia
Optimizing Cognitive Remediation Outcomes in Schizophrenia
Status: Enrolling
Updated: 12/31/1969
San Francisco Veterans Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Alexian Brothers Behavioral Health Hospital
mi
from
Hoffman Estates, IL
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Alexian Brothers Behavioral Health Hospital
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Altea Research Institute
mi
from
Las Vegas, NV
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Altea Research Institute
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Apostle Clinical Trials, Inc
mi
from
Long Beach, CA
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Apostle Clinical Trials, Inc
mi
from
Long Beach, CA
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Behavioral Clinical Research, Inc.
mi
from
North Miami, FL
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Behavioral Clinical Research, Inc.
mi
from
North Miami, FL
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Behavioral Research Specialists, LLC
mi
from
Glendale, CA
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Behavioral Research Specialists, LLC
mi
from
Glendale, CA
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
CNRI - San Diego, LLC
mi
from
San Diego, CA
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
CNRI - San Diego, LLC
mi
from
San Diego, CA
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
CNRI - Los Angeles LLC
mi
from
Pico Rivera, CA
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
CNRI - Los Angeles LLC
mi
from
Pico Rivera, CA
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Community Clinical Research
mi
from
Austin, TX
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Community Clinical Research
mi
from
Austin, TX
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Comprehensive Clinical Development - Cerritos, CA
mi
from
Cerritos, CA
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Comprehensive Clinical Development - Cerritos, CA
mi
from
Cerritos, CA
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
CRI Lifetree
mi
from
Philadelphia, PA
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
CRI Lifetree
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Excell Research, Inc.
mi
from
Oceanside, CA
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Excell Research, Inc.
mi
from
Oceanside, CA
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Florida Clinical Research Center, LLC
mi
from
Orlando, FL
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Florida Clinical Research Center, LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
FutureSearch Clinical Trials LP
mi
from
Austin, TX
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
FutureSearch Clinical Trials LP
mi
from
Austin, TX
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
FutureSearch Clinical Trials, LP
mi
from
Dallas, TX
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
FutureSearch Clinical Trials, LP
mi
from
Dallas, TX
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
J. Gary Booker, MD APMC
mi
from
Shreveport, LA
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
J. Gary Booker, MD APMC
mi
from
Shreveport, LA
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Lake Charles Clinical Trials LLC
mi
from
Lake Charles, LA
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Lake Charles Clinical Trials LLC
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Midwest Clinical Research Center
mi
from
Dayton, OH
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Midwest Clinical Research Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Neurobehavioral Research, Inc.
mi
from
Cedarhurst, NY
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Neurobehavioral Research, Inc.
mi
from
Cedarhurst, NY
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
New Hope Clinical Research
mi
from
Charlotte, NC
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
New Hope Clinical Research
mi
from
Charlotte, NC
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Oklahoma Clinical Research Center
mi
from
Oklahoma City, OK
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Oklahoma Clinical Research Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Pacific Research Partners, LLC
mi
from
Oakland, CA
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Pacific Research Partners, LLC
mi
from
Oakland, CA
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Pillar Clinic Research, LLC
mi
from
Dallas, TX
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Pillar Clinic Research, LLC
mi
from
Dallas, TX
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Synergy Clinical Research of Escondido
mi
from
Escondido, CA
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Synergy Clinical Research of Escondido
mi
from
Escondido, CA
Click here to add this to my saved trials
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated:  12/31/1969
Via Christi Research
mi
from
Wichita, KA
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Status: Enrolling
Updated: 12/31/1969
Via Christi Research
mi
from
Wichita, KA
Click here to add this to my saved trials